Aspg-Gs Double Knockout Selection for CHO Protein Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing CHO cell lines for biopharmaceutical production require improved selection systems to enhance heterologous protein expression, as current methods are time-consuming and laborious, and existing dual selection systems do not adequately increase productivity.

Innovation Solution

A selection system for heterologous protein expression in CHO cells using a double knockout of the asparaginase (Aspg) and glutamine synthetase (Gs) genes, combined with controllably expressed Aspg and Gs vectors, which relies on selective pressure through growth in glutamine-free medium.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a single Gs knockout selection system is used, then the selection process is simple, but the specific productivity and titer of heterologous proteins are insufficient

Engineering Contradiction:
Improvespecific productivityVSAvoidselection system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent combines two selection systems (Gs and Aspg) into a unified dual knockout cell line. The Gs knockout provides glutamine dependence for selection, while the Aspg knockout provides asparagine dependence, creating a synergistic effect that significantly enhances specific productivity and titer of heterologous proteins compared to single knockout systems.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The selection system is divided into two independent but complementary components: the Gs knockout component that confers glutamine auxotrophy, and the Aspg knockout component that confers asparagine auxotrophy. Each component can be independently targeted and selected, allowing for modular optimization of the selection process.

Inventive Principle:
Principle #1Segmentation

2Productivity

If existing dual selection systems are used, then productivity is moderately improved, but the selection process becomes time-consuming and laborious

Engineering Contradiction:
ImprovetiterVSAvoidselection time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent merges Gs and Aspg selection markers into a single dual knockout cell line, allowing simultaneous selection for both markers in one system. This integration reduces the number of separate selection steps required compared to traditional sequential selection methods, thereby reducing time and labor while achieving higher titers.

Inventive Principle:
Principle #5Merging (Combining)

3Productivity

If Aspg knockout is applied alone, then asparagine dependence is achieved, but growth is nearly eliminated in glutamine-free media

Engineering Contradiction:
Improveselection potencyVSAvoidcell growth
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent uses the Gs knockout as an intermediary system that provides glutamine dependence, which serves as a stable foundation for cell growth and selection. The Aspg knockout is then added as a second layer of selection pressure. The Gs system acts as a mediator that supports cell viability while the Aspg system provides enhanced selection potency.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The double knockout system significantly enhances specific productivity and titer of heterologous proteins, achieving up to 15-fold improvement compared to single Gs knockout systems, with stable expression maintained over extended periods.

Implementation Method 1

Aspg, the enzyme which catalyses the deamination of asparagine to aspartate

Methodology Applied
Scientific EffectDeamination: Hydrolysis

Data Source

PatentUS12378573B2Asparaginase based selection system for heterologous protein expression in mammalian cells
Publication Date: 2025.08.05 RGT UNIV OF CALIFORNIA
  • US12378573B2 patent drawing
  • US12378573B2 patent drawing
  • US12378573B2 patent drawing

AI summary

A non-naturally occurring cell comprising an inoperative genomic asparaginase (Aspg) gene and an inoperative glutamine synthetase (Gs) gene, wherein the cell has been transfected with a controllably expressed gene encoding an enzyme having asparaginase activity, a controllably expressed gene encoding an enzyme having glutamine synthetase activity, and a controllably expressed gene encoding a heterologous protein of interest.